One study reported that 43.8% of participants who discontinued treatment did so due to nausea and vomiting, while 36.8% stopped because of gastrointestinal discomfort [14]
2907, Viggers, Rikke, et al
Delivering to All 50 States "I started Ozempic three months ago and struggled with the reduced appetite - I just wasn't eating enough protein
The participant must be at least 18 years old and: Have a BMI of 35 or greater, or Have a BMI of 30 or greater with a diagnosis of diastolic heart failure, uncontrolled hypertension or chronic kidney disease Stage 3a or higher, or Have a BMI of 27 or greater with pre-diabetes, previous myocardial infarction or stroke, or symptomatic peripheral artery disease
[2] [14] This dual-receptor activation distinguishes it from single GLP-1 receptor agonists like semaglutide
Youve likely heard buzz (and seen commercials) about GLP-1 drugs for weight management, like semaglutide (Wegovy) or tirzepatide (Zepbound)
